Funding for this research was provided by:
University of Texas MD Anderson Cancer Center (CA016672)
American Society of Hematology (Junior Faculty Scholar Award in Clinical Research.)
Article History
Accepted: 7 August 2023
First Online: 31 August 2023
Declarations
:
: N. J. S. has served as consultant for Pfizer Inc., GSK, NKARTA, and Sanofi, reports receiving research grants from Takeda Oncology, Astellas Pharma Inc., Xencor, Stemline Therapeutics, and NextCure, and has received honoraria from Novartis, Amgen, Pfizer Inc., Astellas Pharma Inc., Sanofi, and BeiGene. J. S. has been on the Advisory Board of Kite. E. J.: AbbVie: Consultancy, Research Funding; Cyclacel LTD: Research Funding; Pfizer: Consultancy, Research Funding; Takeda: Consultancy, Research Funding; BMS: Consultancy, Research Funding; Adaptive: Consultancy, Research Funding; Amgen: Consultancy, Research Funding.
: This article does not contain any studies with human or animal subjects performed by any of the authors.